147 related articles for article (PubMed ID: 19452252)
1. Absence of tumor-specific over-expression of Polo-like kinase 1 (Plk1) in major non-Hodgkin lymphoma and relatively low expression of Plk1 in nasal NK/T cell lymphoma.
Imai H; Sugimoto K; Isobe Y; Sasaki M; Yasuda H; Takeuchi K; Nakamura S; Kojima Y; Tomomatsu J; Oshimi K
Int J Hematol; 2009 Jun; 89(5):673-8. PubMed ID: 19452252
[TBL] [Abstract][Full Text] [Related]
2. Expression of Polo-Like Kinase (PLK1) in non-Hodgkin's lymphomas.
Mito K; Kashima K; Kikuchi H; Daa T; Nakayama I; Yokoyama S
Leuk Lymphoma; 2005 Feb; 46(2):225-31. PubMed ID: 15621805
[TBL] [Abstract][Full Text] [Related]
3. Investigation of expressions of PDK1, PLK1 and c-Myc in diffuse large B-cell lymphoma.
Feng Y; Lin J; Liu Y; Tang Y; Zhou Y; Zhong M
Int J Exp Pathol; 2019 Feb; 100(1):32-40. PubMed ID: 30912195
[TBL] [Abstract][Full Text] [Related]
4. The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphoma.
Oon ML; Hoppe MM; Fan S; Phyu T; Phuong HM; Tan SY; Hue SS; Wang S; Poon LM; Chan HLE; Lee J; Chee YL; Chng WJ; de Mel S; Liu X; Jeyasekharan AD; Ng SB
Leuk Lymphoma; 2019 Dec; 60(13):3214-3224. PubMed ID: 31259656
[TBL] [Abstract][Full Text] [Related]
5. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
Kanaji S; Saito H; Tsujitani S; Matsumoto S; Tatebe S; Kondo A; Ozaki M; Ito H; Ikeguchi M
Oncology; 2006; 70(2):126-33. PubMed ID: 16645325
[TBL] [Abstract][Full Text] [Related]
6. Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma.
Yasuda H; Sugimoto K; Imai H; Isobe Y; Sasaki M; Kojima Y; Nakamura S; Oshimi K
Eur J Haematol; 2009 Jan; 82(1):39-45. PubMed ID: 18778369
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanisms.
Nguyen T; Parker R; Hawkins E; Holkova B; Yazbeck V; Kolluri A; Kmieciak M; Rahmani M; Grant S
Oncotarget; 2017 May; 8(19):31478-31493. PubMed ID: 28416758
[TBL] [Abstract][Full Text] [Related]
8. Expression of PLK1 and survivin in diffuse large B-cell lymphoma.
Liu L; Zhang M; Zou P
Leuk Lymphoma; 2007 Nov; 48(11):2179-83. PubMed ID: 17943598
[TBL] [Abstract][Full Text] [Related]
9. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
[TBL] [Abstract][Full Text] [Related]
10. The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma.
Zhang Z; Liu E; Zhang D; Zhao W; Wang G; Zhang Y; Huo Y; Zhang C; Li W
Diagn Pathol; 2023 Nov; 18(1):129. PubMed ID: 38037110
[TBL] [Abstract][Full Text] [Related]
11. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
12. Polo-like kinase 1 (Plk1) in cutaneous T-cell lymphoma.
Stutz N; Nihal M; Wood GS
Br J Dermatol; 2011 Apr; 164(4):814-21. PubMed ID: 21070201
[TBL] [Abstract][Full Text] [Related]
13. PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome.
Sandison HE; Usher S; Karimiani EG; Ashton G; Menasce LP; Radford JA; Linton K; Byers RJ
J Clin Pathol; 2013 Sep; 66(9):764-7. PubMed ID: 23757039
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 1 as a new target for non-Hodgkin's lymphoma treatment.
Liu L; Zhang M; Zou P
Oncology; 2008; 74(1-2):96-103. PubMed ID: 18547964
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 expression is a prognostic factor in human colon cancer.
Weichert W; Kristiansen G; Schmidt M; Gekeler V; Noske A; Niesporek S; Dietel M; Denkert C
World J Gastroenterol; 2005 Sep; 11(36):5644-50. PubMed ID: 16237758
[TBL] [Abstract][Full Text] [Related]
17. MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma.
Shi JQ; Lasky K; Shinde V; Stringer B; Qian MG; Liao D; Liu R; Driscoll D; Nestor MT; Amidon BS; Rao Y; Duffey MO; Manfredi MG; Vos TJ; D' Amore N; Hyer ML
Mol Cancer Ther; 2012 Sep; 11(9):2045-53. PubMed ID: 22609854
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis.
Nihal M; Stutz N; Schmit T; Ahmad N; Wood GS
Cell Cycle; 2011 Apr; 10(8):1303-11. PubMed ID: 21436619
[TBL] [Abstract][Full Text] [Related]
19. Secondary parenchymal CNS involvement by lymphoma including rare types: Follicular and EBV-positive NK/T cell lymphoma, nasal type.
Kleinschmidt-DeMasters BK; Gilani A
Ann Diagn Pathol; 2021 Aug; 53():151765. PubMed ID: 34147846
[TBL] [Abstract][Full Text] [Related]
20. Robust diagnosis of non-Hodgkin lymphoma phenotypes validated on gene expression data from different laboratories.
Bhanot G; Alexe G; Levine AJ; Stolovitzky G
Genome Inform; 2005; 16(1):233-44. PubMed ID: 16362926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
